Ownership history in WASATCH ADVISORS LP · 20 quarters on record
This page tracks every 13F SEC filing in which WASATCH ADVISORS LP reported a position in C4 THERAPEUTICS INC (CCCC). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | REDUCED | 4,344,918 | -507,823 | -10.5% | 0.05% | $8.3M | $1.91 |
| 2025 Q3 | REDUCED | 4,852,741 | -2,571,921 | -34.6% | 0.06% | $10.8M | $2.22 |
| 2025 Q2 | ADDED | 7,424,662 | +700,253 | +10.4% | 0.06% | $10.6M | $1.43 |
| 2025 Q1 | ADDED | 6,724,409 | +651,808 | +10.7% | 0.06% | $10.8M | $1.60 |
| 2024 Q4 | ADDED | 6,072,601 | +395,233 | +7.0% | 0.11% | $21.9M | $3.60 |
| 2024 Q3 | ADDED | 5,677,368 | +830,218 | +17.1% | 0.16% | $32.4M | $5.70 |
| 2024 Q2 | ADDED | 4,847,150 | +518,671 | +12.0% | 0.12% | $22.4M | $4.62 |
| 2024 Q1 | REDUCED | 4,328,479 | -2,810,470 | -39.4% | 0.18% | $35.4M | $8.17 |
| 2023 Q4 | ADDED | 7,138,949 | +891,808 | +14.3% | 0.22% | $40.3M | $5.65 |
| 2023 Q3 | REDUCED | 6,247,141 | -952,350 | -13.2% | 0.07% | $11.6M | $1.86 |
As of 2025 Q4 — sorted by position size